Results 161 to 170 of about 2,379 (179)

Therapeutic Drug Monitoring of Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis: Where Are We Now?

Pharmaceutics, 2022
Eva Choong, Laurent Decosterd, Sylvain Blanchon   +2 more
exaly  

Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor

CHEST
Sonia Graziano, Francesca Boldrini, Gaia Romana Pellicano, Francesco Milo, Fabio Majo, Luca Cristiani, Enza Montemitro, Federico Alghisi, Sergio Bella, Renato Cutrera, Alessandro Giovanni Fiocchi, Alexandra Quittner, Paola Tabarini   +12 more
openaire   +1 more source

Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles

American Journal of Respiratory and Critical Care Medicine, 2022
Gesine Hansen, Jens Vogel-Claussen, Mirjam Stahl   +2 more
exaly  

ePS5.08 The effects on systemic inflammation of elexacaftor/tezacaftor/ivacaftor

Journal of Cystic Fibrosis, 2022
N. Robinson, G. Hardisty, R.D. Gray
openaire   +1 more source

Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor–Tezacaftor–Ivacaftor treatment

Frontiers in Immunology, 2023
David Messerer, Christian Karl Braun, Markus Huber-Lang   +2 more
exaly  

Elexacaftor–tezacaftor–ivacaftor as an essential medicine: an opportunity for action

The Lancet Respiratory Medicine
Jonathan, Guo, Andrew, Hill, Cassandra, Fairhead, Benedict, Young, Grace, Hennessy, Gayle, Pledger   +5 more
openaire   +2 more sources

Elexacaftor/Tezacaftor/Ivacaftor in Patients with Cystic Fibrosis Homozygous for the F508del Mutation and Advanced Lung Disease: A 48-Week Observational Study

Journal of Clinical Medicine, 2022
Nicola Ferrara, Vincenzo Carnovale, Paola Iacotucci   +2 more
exaly  

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis

Frontiers in Pharmacology, 2023
Mirjam Stahl, Stephanie Thee, J F Roehmel   +2 more
exaly  

Positive and negative impacts of elexacaftor/tezacaftor/ivacaftor: Healthcare providers' observations across US centers

Pediatric Pulmonology, 2023
Emily Muther, Anna M Georgiopoulos, C J Bathgate   +2 more
exaly  

Suicide attempts in adolescents with cystic fibrosis on Elexacaftor/Tezacaftor/Ivacaftor therapy

Journal of Cystic Fibrosis, 2023
Sarah Chalmers, Mark Wylam, Meliksah Arslan   +2 more
exaly